FDA Approves High Profile Drug - KCBD NewsChannel 11 Lubbock

2/12/04

FDA Approves High Profile Drug

The drug that threw Martha Stewart into court over an insider trading scandal has just been approved by the FDA. Actually, this was the second attempt by drug maker Imclone to try for approval for the colon cancer therapy. It was rejected in 2001, and it was that tip that a negative review by the FDA was coming that led to the trading scandal.

Now, two years later, the drug has been cleared, so what does that mean to patients? The drug is called Erbitux, and it's intended for patients with advanced colon cancer. Studies show Erbitux can shrink tumors in colon cancer patients who are out of treatment options, but it is kind of ironic that the drug that got Martha Stewart in trouble has finally received the government okay, right in the middle of her high profile trial.

Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
publicfile@kcbd.com
806-744-1414
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.